BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang XL, Li ZM, Ye JT, Lu J, Ye LL, Zhang CX, Liu PQ, Duan DD. Pharmacological and cardiovascular perspectives on the treatment of COVID-19 with chloroquine derivatives. Acta Pharmacol Sin 2020;41:1377-86. [PMID: 32968208 DOI: 10.1038/s41401-020-00519-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Kukreja RC, Wang R, Koka S, Das A, Samidurai A, Xi L. Treating diabetes with combination of phosphodiesterase 5 inhibitors and hydroxychloroquine-a possible prevention strategy for COVID-19? Mol Cell Biochem 2022. [PMID: 36036333 DOI: 10.1007/s11010-022-04520-2] [Reference Citation Analysis]
2 Gao X, Jing X, Wang J, Zheng Y, Qiu Y, Ji H, Peng L, Jiang S, Wu W, Guo D. Safety considerations of chloroquine in the treatment of patients with diabetes and COVID-19. Chemico-Biological Interactions 2022. [DOI: 10.1016/j.cbi.2022.109954] [Reference Citation Analysis]
3 Zhang F, Liu W, Huang J, Chen QL, Wang DD, Zou LW, Zhao YF, Zhang WD, Xu JG, Chen HZ, Ge GB. Inhibition of drug-metabolizing enzymes by Jingyin granules: implications of herb-drug interactions in antiviral therapy. Acta Pharmacol Sin 2022;43:1072-81. [PMID: 34183756 DOI: 10.1038/s41401-021-00697-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
4 Açar B. Letter: Multiple Factors Could Affect Blood Pressure in Patients With COVID-19. Angiology 2022;:33197221082335. [PMID: 35239426 DOI: 10.1177/00033197221082335] [Reference Citation Analysis]
5 Denel-bobrowska M, Olejniczak AB. Non-nucleoside structured compounds with antiviral activity—past 10 years (2010–2020). European Journal of Medicinal Chemistry 2022;231:114136. [DOI: 10.1016/j.ejmech.2022.114136] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Poleszak-szabat J, Romaniuk-suswał M, Krukow P. Brief psychotic disorder occurring after Covid-19 in a patient with no history of psychiatric diseases - a case report. Current Problems of Psychiatry 2021;0. [DOI: 10.2478/cpp-2021-0014] [Reference Citation Analysis]
7 Charrez B, Charwat V, Siemons BA, Goswami I, Sakolish C, Luo YS, Finsberg H, Edwards AG, Miller EW, Rusyn I, Healy KE. Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics. Front Pharmacol 2021;12:684252. [PMID: 34421592 DOI: 10.3389/fphar.2021.684252] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Li X, Gao J, Li M, Cui H, Jiang W, Tu ZC, Yuan T. Aromatic Cadinane Sesquiterpenoids from the Fruiting Bodies of Phellinus pini Block SARS-CoV-2 Spike-ACE2 Interaction. J Nat Prod 2021;84:2385-9. [PMID: 34351742 DOI: 10.1021/acs.jnatprod.1c00426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Haji Aghajani M, Toloui A, Aghamohammadi M, Pourhoseingholi A, Taherpour N, Sistanizad M, Madani Neishaboori A, Asadpoordezaki Z, Miri R. Electrocardiographic Findings and In-Hospital Mortality of COVID-19 Patients; a Retrospective Cohort Study. Arch Acad Emerg Med 2021;9:e45. [PMID: 34223190 DOI: 10.22037/aaem.v9i1.1250] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Wong SK. Repurposing New Use for Old Drug Chloroquine against Metabolic Syndrome: A Review on Animal and Human Evidence. Int J Med Sci 2021;18:2673-88. [PMID: 34104100 DOI: 10.7150/ijms.58147] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Li D, Hu J, Li D, Yang W, Yin SF, Qiu R. Reviews on Biological Activity, Clinical Trial and Synthesis Progress of Small Molecules for the Treatment of COVID-19. Top Curr Chem (Cham) 2021;379:4. [PMID: 33428032 DOI: 10.1007/s41061-020-00318-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]